E-DRUG: WHO Pharmaceuticals Newsletter
--------------------------------------------
[WHO/EDM publishes a quarterly newsletter: see http://www.who.int/medicines/organization/qsm/activities/drugsafety/orgpharmanews.shtml
The newsletter is also available by regular email.
Any enquiries related to subscriptions etc. should be directed to pals@who.int
WB]
WHO Pharmaceuticals Newsletter
The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of "drug information officers" and other sources such as specialized bulletins and journals. The information is produced in the form of r�sum�s in English.
E-posting: For automatically receiving new issues of the WHO Pharmaceuticals Newsletter via email (as PDF file), please use our e-posting system.
WHO Pharmaceuticals Newsletter e-posting is an additional service and is not a replacement for the hardcopies of the newsletter that you may already be receiving regularly. Any enquiries related to subscriptions etc. should be directed to pals@who.int
Full texts may be obtained on request from:
Quality Assurance and Safety of Medicines
Essential Drugs and Medicines Policy
World Health Organization
1211 Geneva 27, Switzerland
Fax: +41-22 7914730
email : pals@who.int
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug